Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Franklin Genomic Advancements Fund C (acc) USD Fonds 113697900 / LU2387456242

5.71 USD
-0.07 USD
-1.21 %
7.2.2025
NAV

Nettoinventarwert (NAV)

5.71 USD -0.07 USD -1.21 %
Vortag 5.78 USD Datum 07.02.2025

Franklin Genomic Advancements Fund C (acc) USD Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 346.00%
21Shares Stellar ETP CH1109575535 232.70%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares The Sandbox ETP CH1177361008 134.26%
21Shares Algorand ETP CH1146882316 125.07%
21Shares Sui Staking ETP CH1360612159 39.37%
21Shares Immutable ETP CH1360612142 -34.85%
21Shares Injective Staking ETP CH1360612134 -40.06%
Name ISIN Performance
21Shares Sui Staking ETP CH1360612159 396.35%
21Shares Ripple XRP ETP CH0454664043 300.91%
21Shares Stellar ETP CH1109575535 232.53%
21Shares Aave ETP CH1135202120 153.28%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Algorand ETP CH1146882316 143.59%
21Shares Injective Staking ETP CH1360612134 -16.46%
21Shares Immutable ETP CH1360612142 -33.93%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 367.51%
21Shares Stellar ETP CH1109575535 201.24%
21Shares Aave ETP CH1135202120 181.92%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 165.65%
21Shares Bitcoin Core ETP CH1199067674 115.90%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 784.75%
21Shares Ripple XRP ETP CH0454664043 495.43%
21Shares Bitcoin Core ETP CH1199067674 328.16%
21Shares Bitcoin ETP CH0454664001 317.31%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 281.82%

Fundamentaldaten

Valor 113697900
ISIN LU2387456242
Emittent Franklin Templeton International Services
Aufgelegt in Luxembourg
Auflagedatum 15.10.2021
Kategorie Branchen: Gesundheitswesen
Währung USD
Volumen 3’011’165.14
Depotbank J.P. Morgan SE, Luxembourg Branch
Geschäftsjahresende 30.06.
Berichtsstand 06.02.2025

Anlagepolitik

So investiert der Franklin Genomic Advancements Fund C (acc) USD Fonds: The Fund's investment objective is capital appreciation. The Fund invests principally in equity securities of companies that are relevant to the Fund’s investment theme of genomic advancements. Equity securities generally entitle the holder to participate in a company's general operating results. While the Fund invests predominantly in common stocks, it could also invest in preferred stock, convertible securities and warrants on securities.

ETP Performance: Franklin Genomic Advancements Fund C (acc) USD Fonds

Performance 1 Jahr
-2.23
Performance 2 Jahre
-7.61
Performance 3 Jahre
-25.65
Performance 5 Jahre -
Performance 10 Jahre -